Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Investing

Another Study Shows Nicotine E-Cigarettes Help Smokers to Quit

by June 17, 2024
June 17, 2024
Another Study Shows Nicotine E-Cigarettes Help Smokers to Quit

Jeffrey A. Singer

Finnish researchers published the results of a randomized controlled trial in today’s JAMA Internal Medicine, comparing varenicline (Chantix) to nicotine e‑cigarettes in helping tobacco smokers quit smoking. The researchers concluded, “This randomized clinical trial found that varenicline and nicotine‐​containing ECs were both effective in helping individuals in quitting smoking conventional cigarettes for up to 6 months.”

Varenicline works on receptor sites in the brain to reduce the craving for and satisfaction with nicotine. The Food and Drug Administration denies tobacco smokers wishing to quit access to varenicline unless they get a permission slip (prescription) from a government‐​approved gatekeeper (usually a physician, nurse practitioner, or physician assistant). However, as of 2022, eight states allow pharmacists to prescribe varenicline, sparing smokers the expense in time and money of a visit to the doctor’s office to get a prescription.

This is a significant study because most studies compare varenicline to placebo or e‑cigarettes to placebo. However, this was a high‐​quality comparative effectiveness study. The study was randomized and placebo‐​based, and the participants, study nurses, and researchers were all masked as to group assignment. One group received nicotine e‑cigarettes plus placebo tablets; another group received varenicline and an e‑cigarette that did not contain nicotine; the third group received a nicotine‐​free e‑cigarette and a placebo tablet.

The group of 458 adults (age range 25–75) were given these treatments, along with tobacco cessation counseling, for twelve weeks. After twenty‐​six weeks, the researchers assessed the participants’ quit rates. They found no statistically significant difference between the quit rates of those on varenicline alone vs those on nicotine e‑cigarettes alone (43.8 percent and 40.4 percent, respectively).

In the UK, the National Health Service considers nicotine relatively harmless, considers nicotine e‑cigarettes to be an effective tobacco cessation strategy, and encourages primary care practitioners to suggest it to their patients who smoke. Australia, on the other hand, highly regulates nicotine e‑cigarettes, tightly restricts their supply, and requires people to get a doctor’s prescription for them. Unfortunately, very few Australian doctors will prescribe it, and even if adults who want to quit are fortunate enough to get a doctor’s permission slip, most pharmacies don’t stock them. Australia now has a black market and the associated violent crime one would expect to see with such prohibition.

This study vindicates the NHS’s position regarding e‑cigarettes.

Meanwhile, as the FDA continues its painfully slow process of deciding which e‑cigarettes American adults will be free to buy, and as some politicians wage war on nicotine products, a black market in illicit e‑cigarettes grows.

0
FacebookTwitterGoogle +Pinterest
previous post
Gold Top? Focus on These Potential Price Objectives
next post
It’s TOO EARLY to Be Bullish on Tesla

You may also like

Javier Milei’s Inaugural Promise

December 13, 2023

If Reciprocal Trade Barrier Reductions Are the Goal,...

April 22, 2025

Don’t Let Terrorist Destruction Stop Creative Building

October 31, 2023

Rescissions: A Small but Welcome Step Toward Spending...

June 5, 2025

Will DOGE Hear Crickets on Capitol Hill?

December 10, 2024

Venezuela: How Monetary Mismanagement Contributed to Maduro’s Weakness

July 26, 2024

The Cognitive Shift: How the Terrorist Label May...

March 20, 2025

Can 15-Minute Cities Be Vertical?

April 8, 2024

Federal Housing Tax Credit: 2,060 Pages of Brutal...

March 19, 2024

Will AI Cause Unemployment?

December 4, 2023

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Trump closes week with plans to reposition subs amid heightened Russia tension, new tariffs

      August 2, 2025
    • Inside the Biden cover-up probe: 8 aides questioned, more on the way

      August 2, 2025
    • BROADCAST BIAS: ABC compares Sydney Sweeney ad to Nazis as networks go nuts about her ‘genes’

      August 2, 2025
    • Jeremy Hunt: ‘We’re over-medicalising anxiety and depression with sick notes’

      August 2, 2025
    • Cambodia to nominate Trump for Nobel Peace Prize for role in ending country’s conflict with Thailand

      August 2, 2025
    • WATCH: Trump says he is hopeful Hillary Clinton will be investigated for election fraud

      August 1, 2025

    Categories

    • Business (8,652)
    • Investing (2,168)
    • Politics (16,285)
    • Stocks (3,228)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved